AGENUS INC cotiza a 6.95 USD y tiene una capitalización bursátil de $314M. En los últimos 12 meses ha facturado $133M con un margen de flujo de caja libre del -67.6%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Agenus Inc., a clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally. It offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display tec…
| Métrica | AGEN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 99.1% | 57.0% | +42.1% |
| Operating Margin | -17.7% | -38.6% | +21.0% |
| Net Margin | -0.1% | -33.6% | +33.5% |
| FCF Margin | -67.6% | -13.9% | -53.7% |
| ROE | — | -40.4% | — |
| ROA | -0.0% | -32.0% | +32.0% |
| Current Ratio | 0.41 | 2.84 | -2.43 |
| Debt / Equity | -0.16 | 0.28 | -0.44 |